P04-04. The specific phospholipid binding and neutralizing activities of the anti-HIV antibody 4E10 are separable
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
P04-04. The specific phospholipid binding and neutralizing activities of the anti-HIV antibody 4E10 are separable ; volume:6 ; number:3 ; day:22 ; month:10 ; year:2009 ; pages:1 ; date:10.2009
Retrovirology ; 6, Heft 3 (22.10.2009), 1, 10.2009
- Urheber
-
Xu, H.
- Beteiligte Personen und Organisationen
-
Scherer, E.
Song, L.
Kim, M.
Holmes, MA
Sellhorn, G.
Kraft, Z.
Reinherz, EL
Burton, DR
Stamatatos, L.
Strong, RK
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-6-S3-P32
- URN
-
urn:nbn:de:1111-2016080710295
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Xu, H.
- Scherer, E.
- Song, L.
- Kim, M.
- Holmes, MA
- Sellhorn, G.
- Kraft, Z.
- Reinherz, EL
- Burton, DR
- Stamatatos, L.
- Strong, RK
- SpringerLink (Online service)
Ähnliche Objekte (12)
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Structure‐based discovery of small molecules improving stability of human broadly‐neutralizing anti‐HIV antibody 2F5 in plant suspension cells
Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
Prolonged viral suppression with anti-HIV-1 antibody therapy
P19-03. Molecular mechanisms for enhancing the antigenicity of the carbohydrate epitope of the broadly neutralizing anti-HIV-1 antibody 2G12
Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection
Neutralizing Antibody Sample Testing and Report Harmonization
Neutralizing Antibody Validation Testing and Reporting Harmonization
An improved microtiter assay for evaluating anti-HIV-1 neutralizing antibodies from sera or plasma
Correction to: Neutralizing Antibody Sample Testing and Report Harmonization
Vaccination induces broadly neutralizing antibody precursors to HIV gp41
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Structure‐based discovery of small molecules improving stability of human broadly‐neutralizing anti‐HIV antibody 2F5 in plant suspension cells
Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
Prolonged viral suppression with anti-HIV-1 antibody therapy
P19-03. Molecular mechanisms for enhancing the antigenicity of the carbohydrate epitope of the broadly neutralizing anti-HIV-1 antibody 2G12
Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection
Neutralizing Antibody Sample Testing and Report Harmonization
Neutralizing Antibody Validation Testing and Reporting Harmonization
An improved microtiter assay for evaluating anti-HIV-1 neutralizing antibodies from sera or plasma
Correction to: Neutralizing Antibody Sample Testing and Report Harmonization
Vaccination induces broadly neutralizing antibody precursors to HIV gp41
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Structure‐based discovery of small molecules improving stability of human broadly‐neutralizing anti‐HIV antibody 2F5 in plant suspension cells
Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
Prolonged viral suppression with anti-HIV-1 antibody therapy
P19-03. Molecular mechanisms for enhancing the antigenicity of the carbohydrate epitope of the broadly neutralizing anti-HIV-1 antibody 2G12
Neutralizing anti-HIV antibodies develop in a humanized mouse model of HIV-1 infection
Neutralizing Antibody Sample Testing and Report Harmonization
Neutralizing Antibody Validation Testing and Reporting Harmonization
An improved microtiter assay for evaluating anti-HIV-1 neutralizing antibodies from sera or plasma
Correction to: Neutralizing Antibody Sample Testing and Report Harmonization